Technical Analysis for CTRV - ContraVir Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade F 0.11 -16.03% -0.02
CTRV closed down 16.03 percent on Friday, May 24, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CTRV trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 20 DMA Bullish -16.03%
Stochastic Buy Signal Bullish -16.03%
Pocket Pivot Bullish Swing Setup -16.03%
Wide Bands Range Expansion -16.03%

Older signals for CTRV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies. Its lead candidate, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus. The company has completed Phase I trials of FV-100 in volunteers, as well as a Phase IIa clinical trial in shingles patients. It also plans to conduct a trial in patients with shingles to further explore FV-100's potential to treat the long-lasting nerve pain typically associated with shingles. The company was founded in 2013 and is headquartered in Edison, New Jersey. ContraVir Pharmaceuticals, Inc. is a former subsidiary of Synergy Pharmaceuticals, Inc.
Biopharmaceutical Infectious Diseases Infection Antiviral Drug Viral Diseases Antivirals Herpes Simplex Virology Shingles Varicella Zoster Virus
Is CTRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.6
52 Week Low 0.1
Average Volume 4,043,276
200-Day Moving Average 0.4021
50-Day Moving Average 0.1932
20-Day Moving Average 0.1303
10-Day Moving Average 0.1204
Average True Range 0.0224
ADX 10.09
+DI 22.4503
-DI 18.6979
Chandelier Exit (Long, 3 ATRs ) 0.1203
Chandelier Exit (Short, 3 ATRs ) 0.1672
Upper Bollinger Band 0.162
Lower Bollinger Band 0.0986
Percent B (%b) 0.18
BandWidth 48.656946
MACD Line -0.0218
MACD Signal Line -0.0241
MACD Histogram 0.0023
Fundamentals Value
Market Cap 8.58 Million
Num Shares 78 Million
EPS -0.30
Price-to-Earnings (P/E) Ratio -0.37
Price-to-Sales 0.00
Price-to-Book 5.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.16
Resistance 3 (R3) 0.16 0.15 0.15
Resistance 2 (R2) 0.15 0.14 0.15 0.14
Resistance 1 (R1) 0.13 0.13 0.13 0.13 0.14
Pivot Point 0.12 0.12 0.12 0.12 0.12
Support 1 (S1) 0.10 0.11 0.10 0.10 0.08
Support 2 (S2) 0.09 0.10 0.09 0.08
Support 3 (S3) 0.07 0.09 0.07
Support 4 (S4) 0.07